EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beyond Bioavailability: Lutein Delivery Systems and the Shift Toward Precision Nutrition

Oluwatobi Amusat iD, Sun-Ok Lee iD

Nutrients · 30.10.2026 · 18 (21) · 3607

DOI: 10.3390/nu18213607 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 30.10.2026. Verfasst von Oluwatobi Amusat und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science, Division of Agriculture, University of Arkansas, Fayetteville, AR 72704, USA. Hauptthemen laut MEDLINE: Lutein, Drug Delivery Systems, Precision Medicine. Die Arbeit nennt 228 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lutein is a xanthophyll carotenoid and dietary pigment with an established role in ocular health and potential neuroprotective, hepatoprotective, cardiovascular, and anti-inflammatory effects. Despite this broad biological relevance, average lutein intake in Western populations remains approximately 1–2.2 mg/day, with no established RDI or RDA, while oral bioavailability is limited under typical dietary conditions. Delivery systems, including lipid-based systems, biopolymer matrices, colloidal nanocarriers, and stimuli-responsive smart platforms, have emerged as practical strategies to improve lutein stability, protect it during gastrointestinal transit, and enhance bioaccessibility and systemic exposure. However, genetic variation in uptake-related genes, including SCARB1 and CD36, alongside gut microbiome composition and body composition, may contribute to inter-individual variability in lutein response. Most existing reviews have examined lutein’s health effects, encapsulation, and delivery systems; few have addressed whether formulation performance differs meaningfully among individuals. This review integrates lutein’s chemistry, biological activity, and delivery systems, and considers how formulation design might be matched to individual absorption profiles rather than simply improving average bioavailability across a population. It distinguishes demonstrated delivery outcomes from proposed personalized applications and highlights the human evidence needed to validate this approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LuteinDrug Delivery SystemsPrecision MedicineHumansBiological AvailabilityAnimalsDietary Supplements

Stichwörter der Autor:innen

bioavailabilitycarotenoidsencapsulationgenetic polymorphismsluteinocular healthpersonalized nutrition

Substanzen

Lutein

Autor:innen und Institutionen

  • Department of Food Science, Division of Agriculture, University of Arkansas, Fayetteville, AR 72704, USA.

ORCID-Profile: Oluwatobi Amusat, Sun-Ok Lee

Zitieren

APA

Amusat, O., & Lee, S. O. (2026). Beyond Bioavailability: Lutein Delivery Systems and the Shift Toward Precision Nutrition. Nutrients, 18(21), 3607. https://doi.org/10.3390/nu18213607

Vancouver

Amusat O, Lee SO. Beyond Bioavailability: Lutein Delivery Systems and the Shift Toward Precision Nutrition. Nutrients. 2026;18(21):3607. doi:10.3390/nu18213607

BibTeX
@article{Amusat2026,
  author = {Amusat, Oluwatobi and Lee, Sun-Ok},
  title = {Beyond Bioavailability: Lutein Delivery Systems and the Shift Toward Precision Nutrition},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {21},
  pages = {3607},
  doi = {10.3390/nu18213607}
}
Kostenlos starten →